Paola Alberti, MD, PhD, Board in Neurology
Paola Alberti, MD, PhD, Board in Neurology
School of Medicine and Surgery, University of Milano-Bicocca
Email verificata su - Home page
Citata da
Citata da
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
G Cavaletti, DR Cornblath, ISJ Merkies, TJ Postma, E Rossi, B Frigeni, ...
Annals of Oncology 24 (2), 454-462, 2013
Chemotherapy-induced peripheral neurotoxicity assessment: a critical revision of the currently available tools
G Cavaletti, B Frigeni, F Lanzani, L Mattavelli, E Susani, P Alberti, ...
European journal of cancer 46 (3), 479-494, 2010
Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer
AA Argyriou, G Cavaletti, C Briani, R Velasco, J Bruna, M Campagnolo, ...
Cancer 119 (2), 438-444, 2013
Guillain-Barré syndrome related to COVID-19 infection
P Alberti, S Beretta, M Piatti, A Karantzoulis, ML Piatti, P Santoro, ...
Neurology-Neuroimmunology Neuroinflammation 7 (4), 2020
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics
G Cavaletti, P Alberti, P Marmiroli
The lancet oncology 12 (12), 1151-1161, 2011
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin
P Alberti, E Rossi, DR Cornblath, ISJ Merkies, TJ Postma, B Frigeni, ...
Annals of oncology 25 (1), 257-264, 2014
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients
R Velasco, J Bruna, C Briani, AA Argyriou, G Cavaletti, P Alberti, B Frigeni, ...
Journal of Neurology, Neurosurgery & Psychiatry 85 (4), 392-398, 2014
Voltage‐gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin‐induced peripheral neurotoxicity: Results from a prospective multicenter study
AA Argyriou, G Cavaletti, A Antonacopoulou, AA Genazzani, C Briani, ...
Cancer 119 (19), 3570-3577, 2013
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients
AA Argyriou, R Velasco, C Briani, G Cavaletti, J Bruna, P Alberti, ...
Annals of oncology 23 (12), 3116-3122, 2012
Chemotherapy-induced neuropathy
G Cavaletti, P Alberti, B Frigeni, M Piatti, E Susani
Current treatment options in neurology 13 (2), 180-190, 2011
Chemotherapy‐induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale
B Frigeni, M Piatti, F Lanzani, P Alberti, P Villa, C Zanna, M Ceracchi, ...
Journal of the peripheral nervous system 16 (3), 228-236, 2011
Long‐term course of oxaliplatin‐induced polyneuropathy: a prospective 2‐year follow‐up study
C Briani, AA Argyriou, C Izquierdo, R Velasco, M Campagnolo, P Alberti, ...
Journal of the Peripheral Nervous System 19 (4), 299-306, 2014
Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire
M Van Leeuwen, O Husson, P Alberti, JI Arraras, OL Chinot, A Costantini, ...
Health and quality of life outcomes 16 (1), 114, 2018
Efficacy of a novel sigma-1 receptor antagonist for oxaliplatin-induced neuropathy: a randomized, double-blind, placebo-controlled phase IIa clinical trial
J Bruna, S Videla, AA Argyriou, R Velasco, J Villoria, C Santos, C Nadal, ...
Neurotherapeutics 15 (1), 178-189, 2018
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)
D Binda, EK Vanhoutte, G Cavaletti, DR Cornblath, TJ Postma, B Frigeni, ...
European journal of cancer 49 (13), 2910-2918, 2013
Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer
M Lucchetta, S Lonardi, F Bergamo, P Alberti, R Velasco, AA Argyriou, ...
Cancer chemotherapy and pharmacology 70 (6), 899-902, 2012
Advanced age and liability to oxaliplatin‐induced peripheral neuropathy: post hoc analysis of a prospective study
AA Argyriou, C Briani, G Cavaletti, J Bruna, P Alberti, R Velasco, ...
European journal of neurology 20 (5), 788-794, 2013
Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity?
G Cavaletti, P Alberti, P Marmiroli
American Society of Clinical Oncology Educational Book 35 (1), e553-e560, 2015
Correspondence between neurophysiological and clinical measurements of chemotherapy‐induced peripheral neuropathy: secondary analysis of data from the CI‐PeriNomS study
KA Griffith, SG Dorsey, CL Renn, S Zhu, ME Johantgen, DR Cornblath, ...
Journal of the Peripheral Nervous System 19 (2), 127-135, 2014
Peripheral neuropathy induced by microtubule-targeted chemotherapies: insights into acute injury and long-term recovery
KM Wozniak, JJ Vornov, Y Wu, Y Liu, VA Carozzi, V Rodriguez-Menendez, ...
Cancer research 78 (3), 817-829, 2018
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20